Watford, United Kingdom

Justin Slagel

USPTO Granted Patents = 3 

Average Co-Inventor Count = 1.5

ph-index = 1


Location History:

  • Watford, GB (2020 - 2021)
  • Hertfordshire, GB (2021)

Company Filing History:


Years Active: 2020-2021

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Justin Slagel

Introduction

Justin Slagel is a notable inventor based in Watford, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for various medical conditions. With a total of three patents to his name, Slagel's work demonstrates a commitment to advancing healthcare solutions.

Latest Patents

One of Slagel's latest patents is focused on highly purified eicosapentaenoic acid, as free fatty acid, which has been shown to reduce fecal calprotectin levels and prevent clinical relapse in ulcerative colitis patients. This invention relates to a method of administering an effective dose of highly purified eicosapentaenoic acid (EPA-FFA) to achieve these health benefits. The eicosapentaenoic acid in this formulation boasts a purity of at least 95%, and preferably at least 99%.

Another significant patent involves topical pharmaceutical compositions for the treatment of pilonidal sinus wounds. This composition comprises about 5 wt % to about 12.5 wt % of metronidazole or a pharmacologically acceptable salt thereof in a non-aqueous vehicle. The formulation is designed to treat skin damage resulting from inflammatory skin conditions, burns, infections, or radiation treatment. A key advantage of this composition is that it allows for topical administration of metronidazole, resulting in primarily local effects and minimizing side effects associated with systemic administration.

Career Highlights

Justin Slagel is currently associated with S.L.A. Pharma AG, where he continues to innovate and develop new pharmaceutical solutions. His work is characterized by a focus on improving patient outcomes through effective and targeted treatments.

Collaborations

Slagel collaborates with David Nigel Armstrong, contributing to the advancement of their shared goals in pharmaceutical innovation.

Conclusion

Justin Slagel's contributions to the field of pharmaceuticals through his patents and innovative approaches highlight his dedication to improving healthcare. His work continues to pave the way for new treatments that can significantly benefit patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…